SANOFI VACCINES CANADA LTD. – Trademark Portfolio

Entity Type: 03

SANOFI VACCINES CANADA LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 7 trademarks are registered. Notable registered marks include IPOL, YF-VAX, FLUZONE, TENIVAC, and MENOMUNE. The owner is based in TORONTO.

1755 STEELES AVENUE WEST

TORONTO M2R 3T4 , CA

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TENIVAC
TENIVAC
Registered 2011
IPOL
IPOL
Registered 1990
FLUZONE
FLUZONE
Registered 1986
MENOMUNE
MENOMUNE
Registered 1986
YF-VAX
YF-VAX
Registered 1983
TUBERSOL
TUBERSOL
Registered 1975

Trademark Classifications

SANOFI VACCINES CANADA LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SANOFI VACCINES CANADA LTD. have?

SANOFI VACCINES CANADA LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.

What trademark classes does SANOFI VACCINES CANADA LTD. file in?

SANOFI VACCINES CANADA LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SANOFI VACCINES CANADA LTD.'s most well-known trademarks?

SANOFI VACCINES CANADA LTD.'s registered trademark portfolio includes well-known marks such as IPOL, YF-VAX, FLUZONE, TENIVAC, and MENOMUNE. These are among 7 currently registered trademarks in the portfolio.

What is SANOFI VACCINES CANADA LTD.'s trademark registration success rate?

SANOFI VACCINES CANADA LTD. has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.